Abstract: A polymer composition containing a polyoxymethylene polymer having low shrinkage characteristics and/or an expanded processing window is disclosed. The polymer composition is particularly well suited for use in three-dimensional printing systems, such as printers that use filament fusion technology. The polymer composition, for instance, can be a feed material in the form of a filament or polymeric pellets. The feed material can be placed in a printer cartridge for insertion into a three-dimensional printing system. In accordance with the present disclosure, a polyoxymethylene polymer is combined with one or more dimensional stabilizing agents for dramatically improving the processing characteristics of the polymer.

Abstract: A polymer composition containing a polyoxymethylene polymer having low shrinkage characteristics and/or an expanded processing window is disclosed. The polymer composition is in the form of a powder containing particles having a controlled particle size and particle size distribution. The powder is formulated so as to be used in a three-dimensional printing system, such as a fused bed process.

Abstract: This invention relates generally to methods and pharmaceutical formulations useful in treating patients suffering from sleep apnea, including obstructive sleep apnea syndrome (OSAS). Treatment is effected by administering a carbonic anhydrase inhibitor to the patient in combination with an aldosterone antagonist. Formulations containing a therapeutically effective amount of a carbonic anhydrase inhibitor and a therapeutically effective amount of an aldosterone antagonist are provided as well.

Abstract: Systems and methods are disclosed for directing radiant energy to permanently shadowed or occasionally shadowed regions such as on the floors of craters or in valleys in lunar polar regions to provide illumination, thermal power, electricity, communications, and other services. Embodiments of the systems include reflector elements to provide diffuse illumination, focused illumination, and thermal power, structures to support the reflectors and other elements, communications devices for varied signal types, and methods for installing the system. The structure can be compactly folded and delivered to be automatically installed.

Abstract: A three dimensional system including rendering with variable displacement.

Abstract: A bed can include one or more connectors for connecting components of the bed. For example, a frame can include a fastening mechanism for releasably connecting a cross-member to a longitudinal support. Another example includes connectors for connecting and aligning a foundation with a frame.

Abstract: A three dimensional system including rendering with variable displacement.

Abstract: A three dimensional system including a marker mode.

Abstract: This invention relates generally to methods and pharmaceutical formulations useful in treating patients suffering from sleep apnea, including obstructive sleep apnea syndrome (OSAS). Treatment is effected by administering a carbonic anhydrase inhibitor to the patient in combination with an aldosterone antagonist. Formulations containing a therapeutically effective amount of a carbonic anhydrase inhibitor and a therapeutically effective amount of an aldosterone antagonist are provided as well.

Abstract: A bed can include one or more connectors for connecting components of the bed. For example, a frame can include a fastening mechanism for releasably connecting a cross-member to a longitudinal support. Another example includes connectors for connecting and aligning a foundation with a frame.

Abstract: The present disclosure relates to methods of preventing, treating, delaying the onset of, and delaying the progression of liver disease by administering topiramate in combination with phentermine to a patient in need thereof.

Abstract: A three-dimensional virtual reality environment.

Abstract: A three dimensional system including a marker mode.

Abstract: A three dimensional system including a marker mode.

Abstract: A three dimensional system including a marker mode.

Abstract: A three dimensional system including rendering with variable displacement.

Abstract: The disclosed embodiments relate to, dosing regimens for the administration of topiramate, optionally in combination with one or more sympathomimetic agents such as phentermine. The dosing regimens can, for example, limit the exposure of subjects to topiramate, identify subjects who are unlikely to obtain a benefit from treatment with escalating dosages of topiramate (with or without the sympathomimetic agent, such as phentermine), or both, thereby reducing or eliminating harmful or intolerable side effects in subjects who are unlikely to respond to treatment and maximizing the therapeutic benefits from treatment in subjects who do respond.

Abstract: A three dimensional system including lens modeling.

Abstract: A three dimensional system including rendering with variable displacement.

Abstract: A three dimensional system including rendering with eye displacement.